| Market Cap | ₹23,920Cr |
| ROE | -0.29% |
| P/E Ratio(TTM) | -999.72 |
| EPS(TTM) | -0.18 |
| P/B Ratio | 2.96 |
| Dividend Yield | 0.08% |
| Industry P/E | 33.40 |
| Book Value | 60.77 |
| Debt to Equity | 0.60 |
| Face Value | 10 |
| Parent Organisation | Piramal Pharma |
| NSE Symbol | PPLPHARMA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 41.30 | ||
| Cipla | NA (0.00%) | 22.60 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.55 | ||
| Lupin | NA (0.00%) | 22.04 |